Search

everythinglearnresearchcommunity

for

Search:↓

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Third booster shots enhance the immune system's response to the COVID-19 virus.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

ILC1-like cells can independently cause alopecia areata.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.